Morgan Stanley
GELS

Morgan Stanley’s Gelteq Ltd GELS Stock Holding History

Morgan Stanley’s Portfolio GELS Stock Details GELS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-651
Closed -$898 – 8533
2025
Q3 		$898 Buy
+651
New +$1.01K ﹤0.01% 7396
2025
Q2 		– Sell
-3,500
Closed -$3.64K – 8318
2025
Q1 		$3.64K Buy
+3,500
New +$6.55K ﹤0.01% 7067

Other funds holding GELS

Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Morgan Stanley's GELS Position: Q4 2025 in Review

Morgan Stanley sold out of Gelteq Ltd (GELS) in Q4 2025, closing a stake of 651 shares — an estimated $898 sold.

Morgan Stanley first reported a position in GELS in Q1 2025 and held it in 2 quarters. The position peaked at $3.64K in Q1 2025. 3 funds tracked by Wall St. Rank hold GELS as of Q4 2025.

  • Morgan Stanley reported no remaining Gelteq Ltd position as of Q4 2025 after selling out during the quarter.
  • Morgan Stanley sold 651 Gelteq Ltd shares in Q4 2025, an estimated $898.
  • Morgan Stanley first reported a position in Gelteq Ltd in Q1 2025 and held it in 2 quarters.
  • Morgan Stanley's Gelteq Ltd position peaked at $3.64K in Q1 2025.
  • 3 funds tracked by Wall St. Rank held Gelteq Ltd as of Q4 2025.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.